|
| BRAFmutant hematopoietic malignancies |
|
https://doi.org/10.18632/oncotarget.2448
Omar Abdel-Wahab, and Christopher Y. Park
|
| 7980-7981 |
|
| The reverse Warburg effect in osteosarcoma |
|
https://doi.org/10.18632/oncotarget.2352
Federica Sotgia, Ubaldo E. Martinez-Outschoorn, and Michael P. Lisanti
|
| 7982-7983 |
|
| ‘Sex’ in the cancer cell |
|
https://doi.org/10.18632/oncotarget.2355
Inam J. Lafta, Helen E. Bryant, and Alastair S. H. Goldman
|
| 7984-7985 |
|
| Oncogene addiction: resetting the safety switch |
|
https://doi.org/10.18632/oncotarget.2474
Yulin Li, Peter S. Choi, and Dean W. Felsher
|
| 7986-7987 |
|
| Screening for E3Ubiquitin ligase inhibitors: challenges and opportunities |
|
https://doi.org/10.18632/oncotarget.2431
Vivien Landré, Barak Rotblat, Sonia Melino, Francesca Bernassola, and Gerry Melino
|
| 7988-8013 |
|
| The IGF signalling pathway in Wilms tumours A report from the ENCCA Renal Tumours Biologydriven drug development workshop |
|
https://doi.org/10.18632/oncotarget.2485
Mariana Maschietto, Jocelyn Charlton, Daniela Perotti, Paolo Radice, James I. Geller, Kathy Pritchard-Jones, and Mark Weeks
|
| 8014-8026 |
|
| Correlation of long noncoding RNA expression with metastasis drug resistance and clinical outcome in cancer |
|
https://doi.org/10.18632/oncotarget.2469
Ehsan Malek, Sajjeev Jagannathan, and James J. Driscoll
|
| 8027-8038 |
|
| Regulatory roles of LINE1encoded reverse transcriptase in cancer onset and progression |
|
https://doi.org/10.18632/oncotarget.2504
Ilaria Sciamanna, Alberto Gualtieri, Pier Vincenzo Piazza, and Corrado Spadafora
|
| 8039-8051 |
|
| CUSP9* treatment protocol for recurrent glioblastoma: aprepitant artesunate auranofin captopril celecoxib disulfiram itraconazole ritonavir sertraline augmenting continuous low dose temozolomide |
|
https://doi.org/10.18632/oncotarget.2408
Richard E. Kast, Georg Karpel-Massler, and Marc-Eric Halatsch
|
| 8052-8082 |
|
| Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas |
|
https://doi.org/10.18632/oncotarget.2342
Jane B. Cryan, Sam Haidar, Lori A. Ramkissoon, Wenya Linda Bi, David S. Knoff, Nikolaus Schultz, Malak Abedalthagafi, Loreal Brown, Patrick Y. Wen, David A. Reardon, Ian F. Dunn, Rebecca D. Folkerth, Sandro Santagata, Neal I. Lindeman, Azra H. Ligon, Rameen Beroukhim, Jason L. Hornick, Brian M. Alexander, Keith L. Ligon, and Shakti H. Ramkissoon
|
| 8083-8092 |
|
| Anticancer potency of tasquinimod is enhanced via albuminbinding facilitating increased uptake in the tumor microenvironment |
|
https://doi.org/10.18632/oncotarget.2378
John T. Isaacs, Susan L. Dalrymple, Marc D. Rosen, Hans Hammers, Anders Olsson, and Tomas Leanderson
|
| 8093-8106 |
|
| TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity |
|
https://doi.org/10.18632/oncotarget.2440
Dongshi Chen, Lihua Ming, Fangdong Zou, Ye Peng, Bennett Van Houten, Jian Yu, and Lin Zhang
|
| 8107-8122 |
|
| Identification of a DNA methylation signature to predict diseasefree survival in locally advanced rectal cancer |
|
https://doi.org/10.18632/oncotarget.2347
Jochen Gaedcke, Andreas Leha, Rainer Claus, Dieter Weichenhan, Klaus Jung, Julia Kitz, Marian Grade, Hendrik A. Wolff, Peter Jo, Jérôme Doyen, Jean-Pierre Gérard, Steven A. Johnsen, Christoph Plass, Tim Beißbarth, and Michael Ghadimi
|
| 8123-8135 |
|
| A first in man phase I trial of the oral immunomodulator indoximod combined with docetaxel in patients with metastatic solid tumors |
|
https://doi.org/10.18632/oncotarget.2357
Hatem H. Soliman, Erica Jackson, Tony Neuger, Claire E. Dees, Donald R. Harvey, Hyo Han, Roohi Ismail-Khan, Susan Minton, Nicholas N. Vahanian, Charles Link, Daniel M. Sullivan, and Scott Antonia
|
| 8136-8146 |
|
| Coexpression of MET and CD47 is a novel prognosticator for survival of luminaltype breast cancer patients |
|
https://doi.org/10.18632/oncotarget.2385
Irène Baccelli, Albrecht Stenzinger, Vanessa Vogel, Berit Maria Pfitzner, Corinna Klein, Markus Wallwiener, Martina Scharpff, Massimo Saini, Tim Holland-Letz, Hans-Peter Sinn, Andreas Schneeweiss, Carsten Denkert, Wilko Weichert, and Andreas Trumpp
|
| 8147-8160 |
|
| A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors |
|
https://doi.org/10.18632/oncotarget.2415
Gideon M. Blumenthal, Joell J. Gills, Marc S. Ballas, Wendy B. Bernstein, Takefumi Komiya, Roopa Dechowdhury, Betsy Morrow, Hyejeong Root, Guinevere Chun, Cynthia Helsabeck, Seth M. Steinberg, Jaclyn LoPiccolo, Shigeru Kawabata, Erin R. Gardner, William D. Figg, and Phillip A. Dennis
|
| 8161-8172 |
|
| A screen for transcription factor targets of glycogen synthase kinase3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2303
Victor M. Campa, Eder Baltziskueta, Nora Bengoa-Vergniory, Irantzu Gorroño-Etxebarria, Radosław Wesołowski, Jonathan Waxman, and Robert M. Kypta
|
| 8173-8187 |
|
| Wogonin induces cell cycle arrest and erythroid differentiation in imatinibresistant K562 cells and primary CML cells |
|
https://doi.org/10.18632/oncotarget.2340
Hao Yang, Hui Hui, Qian Wang, Hui Li, Kai Zhao, Yuxin Zhou, Yu Zhu, Xiaotang Wang, Qidong You, Qinglong Guo, and Na Lu
|
| 8188-8201 |
|
| Tissuespecific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers |
|
https://doi.org/10.18632/oncotarget.1159
Shruti Desai, Minming Ding, Bin Wang, Zhimin Lu, Qi Zhao, Kenna Shaw, W K Alfred Yung, John N Weinstein, Ming Tan, and Jun Yao
|
| 8202-8210 |
|
| Targeting CD13 aminopeptidaseN in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells |
|
https://doi.org/10.18632/oncotarget.1788
Sandrine Bouchet, Ruoping Tang, Fanny Fava, Ollivier Legrand, and Brigitte Bauvois
|
| 8211-8222 |
|
| Population distribution and ancestry of the cancer protective MDM2 SNP285 rs117039649 |
|
https://doi.org/10.18632/oncotarget.1910
Stian Knappskog, Liv B. Gansmo, Khadizha Dibirova, Andres Metspalu, Cezary Cybulski, Paolo Peterlongo, Lauri Aaltonen, Lars Vatten, PÃ¥l Romundstad, Kristian Hveem, Peter Devilee, Gareth D. Evans, Dongxin Lin, Guy Van Camp, Vangelis G. Manolopoulos, Ana Osorio, Lili Milani, Tayfun Ozcelik, Pierre Zalloua, Francis Mouzaya, Elena Bliznetz, Elena Balanovska, Elvira Pocheshkova, Vaidutis KuÄinskas, Lubov Atramentova, Pagbajabyn Nymadawa, Konstantin Titov, Maria Lavryashina, Yuldash Yusupov, Natalia Bogdanova, Sergey Koshel, Jorge Zamora, David C. Wedge, Deborah Charlesworth, Thilo Dörk, Oleg Balanovsky, and Per E. Lønning
|
| 8223-8234 |
|
| Activation of EGFR HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice |
|
https://doi.org/10.18632/oncotarget.1632
Sandra Dupouy, Van Kien Doan, Zherui Wu, Najat Mourra, Olivier De Wever, Frédérique Penault Llorca, Anne Cayre, Amal Kouchkar, Anne Gompel, and Patricia Forgez
|
| 8235-8251 |
|
| Neurotensin NTS and its receptor NTSR1 causes EGFR HER2 and HER3 overexpression and their autocrine/paracrine activation in lung tumors confirming responsiveness to erlotinib |
|
https://doi.org/10.18632/oncotarget.1633
Mohamad Younes, Zherui Wu, Sandra Dupouy, Audrey Mansuet Lupo, Najat Mourra, Takashi Takahashi, Jean-Francois Flejou, Jean Trédaniel, Jean François Régnard, Diane Damotte, Marco Alifano, and Patricia Forgez
|
| 8252-8269 |
|
| Oncogenic RASinduced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved |
|
https://doi.org/10.18632/oncotarget.2013
Maria Grazia Vizioli, Joana Santos, Silvana Pilotti, Mara Mazzoni, Maria Chiara Anania, Claudia Miranda, Sonia Pagliardini, Marco A. Pierotti, Jesus Gil, and Angela Greco
|
| 8270-8283 |
|
| Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease |
|
https://doi.org/10.18632/oncotarget.2058
Antonio Garcia-Gomez, Javier De Las Rivas, Enrique M. Ocio, Elena DÃaz-RodrÃguez, Juan C. Montero, Montserrat MartÃn, Juan F. Blanco, FermÃn M. Sanchez-Guijo, Atanasio Pandiella, Jesús F. San Miguel, and Mercedes Garayoa
|
| 8284-8305 |
|
| Chemical inhibition of acetylCoA carboxylase suppresses selfrenewal growth of cancer stem cells |
|
https://doi.org/10.18632/oncotarget.2059
Bruna Corominas-Faja, Elisabet Cuyà s, Juan Gumuzio, Joaquim Bosch-Barrera, Olatz Leis, Ãngel G. Martin, and Javier A. Menendez
|
| 8306-8316 |
|
| Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression |
|
https://doi.org/10.18632/oncotarget.2135
Guangchao Li, Likun Zhao, Wei Li, Kexing Fan, Weizhu Qian, Sheng Hou, Hao Wang, Jianxin Dai, Huafeng Wei, and Yajun Guo
|
| 8317-8329 |
|
| Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NFκB signaling pathway |
|
https://doi.org/10.18632/oncotarget.2212
Ning Zhang, Eagle S. H. Chu, Jingwan Zhang, Xiaoxing Li, Qiaoyi Liang, Jie Chen, Minhu Chen, Narci Teoh, Geoffrey Farrell, Joseph J. Y. Sung, and Jun Yu
|
| 8330-8340 |
|
| HMGA1 pseudogenes as candidate protooncogenic competitive endogenous RNAs |
|
https://doi.org/10.18632/oncotarget.2202
Francesco Esposito, Marco De Martino, Maria Grazia Petti, Floriana Forzati, Mara Tornincasa, Antonella Federico, Claudio Arra, Giovanna Maria Pierantoni, and Alfredo Fusco
|
| 8341-8354 |
|
| ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature |
|
https://doi.org/10.18632/oncotarget.2247
Lynn Roy, Serene J. Samyesudhas, Martin Carrasco, Jun Li, Stancy Joseph, Richard Dahl, and Karen D. Cowden Dahl
|
| 8355-8366 |
|
| Oncogenetriggered suppression of DNA repair leads to DNA instability in cancer |
|
https://doi.org/10.18632/oncotarget.2259
Julia A. Yaglom, Christopher McFarland, Leonid Mirny, and Michael Y. Sherman
|
| 8367-8378 |
|
| Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulinlike growth factor1 receptorindependent mechanism |
|
https://doi.org/10.18632/oncotarget.2292
Ahmed Waraky, Karen Akopyan, Vendela Parrow, Thomas Strömberg, Magnus Axelson, Lars Abrahmsén, Arne Lindqvist, Olle Larsson, and Eiman Aleem
|
| 8379-8392 |
|
| TALENmediated Nanog disruption results in less invasiveness more chemosensitivity and reversal of EMT in Hela cells |
|
https://doi.org/10.18632/oncotarget.2298
Yan Ding, Ai Qing Yu, Cheng Lin Li, Juan Fang, Yi Zeng, and Dong Sheng Li
|
| 8393-8401 |
|
| Therapeutic effect of a TM4SF5specific monoclonal antibody against colon cancer in a mouse model |
|
https://doi.org/10.18632/oncotarget.2311
Young-Eun Kim, Sanghoon Kwon, Guang Wu, Dongbum Kim, Byoung Kwon Park, Jeong-A Park, Kyung-Chan Choi, Doo-Sik Kim, Hyung-Joo Kwon, and Younghee Lee
|
| 8402-8415 |
|
| Inhibition of STAT3 signaling targets both tumorinitiating and differentiated cell populations in prostate cancer |
|
https://doi.org/10.18632/oncotarget.2314
Zhiqiang Han, Xiaoli Wang, Liang Ma, Lijuan Chen, Min Xiao, Liang Huang, Yang Cao, Jian Bai, Ding Ma, Jianfeng Zhou, and Zhenya Hong
|
| 8416-8428 |
|
| Interferonstimulated gene 15 ISG15 is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.2316
Chong Li, Ji Wang, Hong Zhang, Mingao Zhu, Feifei Chen, Yufeng Hu, Hudan Liu, and Hong Zhu
|
| 8429-8441 |
|
| Regulatory effects of a Mnk2eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells |
|
https://doi.org/10.18632/oncotarget.2319
Frank Eckerdt, Elspeth Beauchamp, Jonathan Bell, Asneha Iqbal, Bing Su, Rikiro Fukunaga, Rishi R. Lulla, Stewart Goldman, and Leonidas C. Platanias
|
| 8442-8451 |
|
| Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory ComplexI activity via Bcl2 family proteins |
|
https://doi.org/10.18632/oncotarget.2320
Eun Mi Kim, Jong Kuk Park, Sang-Gu Hwang, Wun-Jae Kim, Zheng-Gang Liu, Sang Won Kang, and Hong-Duck Um
|
| 8452-8465 |
|
| PIWIL2 induces cMyc expression by interacting with NME2 and regulates cMycmediated tumor cell proliferation |
|
https://doi.org/10.18632/oncotarget.2327
Youlin Yao, Chao Li, Xiaoyan Zhou, Yu Zhang, Yilu Lu, Jianhui Chen, Xulei Zheng, Dachang Tao, Yunqiang Liu, and Yongxin Ma
|
| 8466-8477 |
|
| The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via NMyc downstreamregulated gene 2 NDRG2/gp130/STAT3 pathway |
|
https://doi.org/10.18632/oncotarget.2328
Jiabei Wang, Dalong Yin, Changming Xie, Tongsen Zheng, Yingjian Liang, Xuehui Hong, Zhaoyang Lu, Xuan Song, Ruipeng Song, Haiyan Yang, Boshi Sun, Nishant Bhatta, Xianzhi Meng, Shangha Pan, Hongchi Jiang, and Lianxin Liu
|
| 8478-8491 |
|
| Spinophilin expression determines cellular growth cancer stemness and 5flourouracil resistance in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.2329
Anna Lena Ress, Verena Stiegelbauer, Daniela Schwarzenbacher, Alexander Deutsch, Samantha Perakis, Hui Ling, Cristina Ivan, George Adrian Calin, Beate Rinner, Armin Gerger, and Martin Pichler
|
| 8492-8502 |
|
| The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets |
|
https://doi.org/10.18632/oncotarget.2330
Kumar Saurabh, Michael T. Scherzer, Parag P. Shah, Alice S. Mims, William W. Lockwood, Andrew S. Kraft, and Levi J. Beverly
|
| 8503-8514 |
|
| Efficient lytic induction of kaposi’s sarcomaassociated herpesvirus KSHV by the anthracyclines |
|
https://doi.org/10.18632/oncotarget.2335
Hyunju Kang, Jaehyung Song, Kwangman Choi, Hyeongki Kim, Miri Choi, So-Young Lee, Chonsaeng Kim, Sang Jun Lee, Moon Jung Song, Hyojeung Kang, Sung Hoon Back, Sang-Bae Han, and Sungchan Cho
|
| 8515-8527 |
|
| Inhibition of lung tumor growth by targeting EGFR/VEGFRAkt/NFκB pathways with novel theanine derivatives |
|
https://doi.org/10.18632/oncotarget.2336
Guoying Zhang, Xinshan Ye, Dexin Ji, Huarong Zhang, Fujia Sun, Chunqing Shang, Ying Zhang, Erxi Wu, Fengfei Wang, Fei Wu, Huihui Tian, Xin Liu, Linlin Chen, Kun Liu, Hanchen Liu, Yishan Wang, Wenhua Zhang, Yukun Guan, Qinwen Wang, Xiaohang Zhao, and Xiaochun Wan
|
| 8528-8543 |
|
| Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors |
|
https://doi.org/10.18632/oncotarget.2337
Burhan Hassan, Argun Akcakanat, Takafumi Sangai, Kurt W. Evans, Farrell Adkins, Agda Karina Eterovic, Hao Zhao, Ken Chen, Huiqin Chen, Kim-Anh Do, Shelly M. Xie, Ashley M. Holder, Aung Naing, Gordon B. Mills, and Funda Meric-Bernstam
|
| 8544-8557 |
|
| Loss of the obscurinRhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells |
|
https://doi.org/10.18632/oncotarget.2338
Nicole A. Perry, Michele I. Vitolo, Stuart S. Martin, and Aikaterini Kontrogianni-Konstantopoulos
|
| 8558-8568 |
|
| ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2322
Jian-Jun Xie, Yang-Min Xie, Bo Chen, Feng Pan, Jin-Cheng Guo, Qing Zhao, Jin-Hui Shen, Zhi-Yong Wu, Jian-Yi Wu, Li-Yan Xu, and En-Min Li
|
| 8569-8582 |
|
| EpsteinBarr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma |
|
https://doi.org/10.18632/oncotarget.2323
Shih-Hsin Chiu, Chung-Chun Wu, Chih-Yeu Fang, Shu-Ling Yu, Hui-Yu Hsu, Yen-Hung Chow, and Jen-Yang Chen
|
| 8583-8601 |
|
| Interfering with the interaction between ErbB1 nucleolin and Ras as a potential treatment for glioblastoma |
|
https://doi.org/10.18632/oncotarget.2343
Yona Goldshmit, Sari Schokoroy Trangle, Yoel Kloog, and Ronit Pinkas-Kramarski
|
| 8602-8613 |
|
| Selective targeting of liver cancer with the endothelial marker CD146 |
|
https://doi.org/10.18632/oncotarget.2345
Stefan Thomann, Thomas Longerich, Alexandr V. Bazhin, Walter Mier, Peter Schemmer, and Eduard Ryschich
|
| 8614-8624 |
|
| Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas |
|
https://doi.org/10.18632/oncotarget.2349
Haiyang Guo, Xiyu Zhang, Ruifen Dong, Xiaolin Liu, Yinuo Li, Shan Lu, Limei Xu, Yuqiong Wang, Xiyao Wang, Dong Hou, Jian-Jun Wei, Changshun Shao, and Zhaojian Liu
|
| 8625-8636 |
|
| Selective JAK2/ABL dual inhibition therapy effectively eliminates TKIinsensitive CML stem/progenitor cells |
|
https://doi.org/10.18632/oncotarget.2353
Hanyang Lin, Min Chen, Katharina Rothe, Matthew V. Lorenzi, Adrian Woolfson, and Xiaoyan Jiang
|
| 8637-8650 |
|
| Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease |
|
https://doi.org/10.18632/oncotarget.2354
Heidi N. Hilton, Tram B. Doan, J. Dinny Graham, Samantha R. Oakes, Audrey Silvestri, Nicole Santucci, Silke Kantimm, Lily I. Huschtscha, Christopher J. Ormandy, John W. Funder, Evan R. Simpson, Elizabeth S. Kuczek, Peter J. Leedman, Wayne D. Tilley, Peter J. Fuller, George E. O. Muscat, and Christine L. Clarke
|
| 8651-8664 |
|
| Induced cancer stemlike cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell |
|
https://doi.org/10.18632/oncotarget.2356
Mayuko Nishi, Hidenori Akutsu, Ayumi Kudoh, Hirokazu Kimura, Naoki Yamamoto, Akihiro Umezawa, Sam W. Lee, and Akihide Ryo
|
| 8665-8680 |
|
| Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer |
|
https://doi.org/10.18632/oncotarget.2365
Antje Neeb, Simon Hefele, Stefanie Bormann, Walther Parson, Fabian Adams, Philipp Wolf, Arkadiusz Miernik, Martin Schoenthaler, Malte Kroenig, Konrad Wilhelm, Wolfgang Schultze-Seemann, Sigrun Nestel, Georg Schaefer, Huajie Bu, Helmut Klocker, Irina Nazarenko, and Andrew C. B. Cato
|
| 8681-8689 |
|
| Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZB differentially regulate glioma cell growth and motility |
|
https://doi.org/10.18632/oncotarget.2366
Annika M. Bourgonje, Anna C. Navis, Jan T.G. Schepens, Kiek Verrijp, Liesbeth Hovestad, Riet Hilhorst, Sheila Harroch, Pieter Wesseling, William P.J. Leenders, and Wiljan J.A.J. Hendriks
|
| 8690-8702 |
|
| Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors |
|
https://doi.org/10.18632/oncotarget.2367
Ayesha B. Alvero, Michele K. Montagna, Natalia J. Sumi, Won Duk Joo, Emma Graham, and Gil Mor
|
| 8703-8715 |
|
| IL6stimulated CD11b+ CD14+ HLADR− myeloidderived suppressor cells are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus |
|
https://doi.org/10.18632/oncotarget.2368
Miao-Fen Chen, Feng-Che Kuan, Tzu-Chen Yen, Ming-Shian Lu, Paul-Yang Lin, Yi-Hsiu Chung, Wen-Cheng Chen, and Kuan-Der Lee
|
| 8716-8728 |
|
| Selective methioninaseinduced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity |
|
https://doi.org/10.18632/oncotarget.2369
Shuya Yano, Shukuan Li, Qinghong Han, Yuying Tan, Michael Bouvet, Toshiyoshi Fujiwara, and Robert M. Hoffman
|
| 8729-8736 |
|
| Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALKmutated neuroblastoma |
|
https://doi.org/10.18632/oncotarget.2372
Nathan F. Moore, Anna M. Azarova, Namrata Bhatnagar, Kenneth N. Ross, Lauren E. Drake, Stacey Frumm, Qinsong S. Liu, Amanda L. Christie, Takaomi Sanda, Louis Chesler, Andrew L. Kung, Nathanael S. Gray, Kimberly Stegmaier, and Rani E. George
|
| 8737-8749 |
|
| Using heterogeneity of the patientderived xenograft model to identify the chemoresistant population in ovarian cancer |
|
https://doi.org/10.18632/oncotarget.2373
Zachary C. Dobbin, Ashwini A. Katre, Adam D. Steg, Britt K. Erickson, Monjri M. Shah, Ronald D. Alvarez, Michael G. Conner, David Schneider, Dongquan Chen, and Charles N. Landen
|
| 8750-8764 |
|
| Interleukin32α downregulates the activity of the Bcell CLL/lymphoma 6 protein by inhibiting protein kinase Cεdependent SUMO2 modification |
|
https://doi.org/10.18632/oncotarget.2364
Yun Sun Park, Jeong-Woo Kang, Dong Hun Lee, Man Sub Kim, Yesol Bak, Young Yang, Hee Gu Lee, JinTae Hong, and Do-Young Yoon
|
| 8765-8777 |
|
| p21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT and ERKdependent activation of NFκB pathway |
|
https://doi.org/10.18632/oncotarget.2398
Nikhil Tyagi, Arun Bhardwaj, Ajay P. Singh, Steven McClellan, James E. Carter, and Seema Singh
|
| 8778-8789 |
|
| IsomiR expression profiles in human lymphoblastoid cell lines exhibit population and gender dependencies |
|
https://doi.org/10.18632/oncotarget.2405
Phillipe Loher, Eric R. Londin, and Isidore Rigoutsos
|
| 8790-8802 |
|
| POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in Head and Neck cancer |
|
https://doi.org/10.18632/oncotarget.2492
Daniel J. Sharpe, Katy S. Orr, Michael Moran, Sharon J. White, Stephen McQuaid, Terence R. Lappin, Alexander Thompson, and Jacqueline A. James
|
| 8803-8815 |
